Biotricity Inc. (OTCQB: BTCY) and B-Secur announced on September 3, 2025, an enhancement to their joint cardiac monitoring platform, now targeting the consumer wearables market. This expands their device-neutral platform, initially launched in early 2025 for ambulatory cardiac monitoring.
The enhanced platform will support ECG data from consumer wearables, including smartwatches, smart rings, and fitness trackers. This enables seamless integration and review of user data within Biotricity’s cloud-based medical workflow.
This strategic move solidifies the companies' leadership in digital cardiovascular innovation, positioning them at the forefront of the rapidly expanding heart health market. It aims to provide clinical-grade heart monitoring to consumers, bridging the gap between consumer devices and clinical care.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.